GLUE Monte Rosa Therapeutics, Inc.

$14.07▼ -1.75% Healthcare Other
After hours $14.07▲ +0.00% Sep 11, 7:30 PM ET
Volume 1.17M Avg Volume (10D) 1.03M
Key Metrics & Fundamentals
Market Cap
$1.20B
P/E Ratio
–
Div Yield
–%
52W Range
4.80 - 25.77
% vs 50 MA
-22.94%
% vs 200 MA
-24.05%
RSI-14
38.2
MACD Histogram
+0.2400
Beta (1Y vs SPY)
0.81
Free Cash Flow
-$48.84M
Gross Rev
$8.97M
Gross Profit
$8.97M
EBITDA
-$47.24M
COGS
–
Operating Exp
$58.10M
Operating Income
-$49.13M
EBIT
-$49.13M
Pretax Income
-$43.19M
Net Income
-$43.40M
EPS (Diluted)
-0.51
Price & Volume History
Loading chart…
Recent News
Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon
MT Newswires · Sep 8, 2026 3:45 PM
Monte Rosa to Receive $50 Million Milestone Payment From Novartis for Phase 2 Launch of MRT-6160
MT Newswires · Sep 8, 2026 12:18 PM
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
GlobeNewswire · Sep 8, 2026 11:00 AM
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 2, 2026 8:01 PM
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 11:00 AM
Monte Rosa Therapeutics Doses First Patient in Phase 2 Prostate Cancer Study
MT Newswires · Aug 24, 2026 12:25 PM
Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer
GlobeNewswire · Aug 24, 2026 11:00 AM
Monte Rosa Therapeutics (GLUE) Is Down 30.7% After Deepening Q2 Losses And H1 Earnings Reversal
Simply Wall St. · Aug 7, 2026 7:10 AM
Monte Rosa Therapeutics (GLUE) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 6, 2026 1:50 PM
Monte Rosa Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 11:27 AM
Financial Overview - Income Statement Quarterly

See GLUE's money flow as a full page

Social Sentiment
Avg -0.36 · 9 posts
Alaska Air Group: The Glue is Coming Unstuck
r/stocks · Jan 10, 2026
The post expresses a short position in ALK and highlights concerns about the profitability and accounting practices of the loyalty program, suggesting a bearish outlook.
negative -0.60
$ENVX Enovix Corp undertaking transformative battery tech
r/stocks · Jul 22, 2025
While the post discusses Enovix, the top comment reveals successful trading and a significant opportunity, suggesting a bullish sentiment towards the company and indirectly the ETF.
positive +0.60
Tesla Earnings: The Old Used Kleenex Trick Works Again
r/stocks · Apr 24, 2025
The post expresses significant concerns about Tesla's financial performance and future prospects, indicating a bearish sentiment towards the stock.
negative -0.60
Self-driving car safety experts at NHTSA that regulates Tesla removed - potentially increasing roll out of FSD timeline and SaaS fees
r/stocks · Apr 10, 2025
The comments express strong criticism of Tesla's FSD, implying a negative outlook on the company and potentially affecting GLUE's competitive position.
negative -0.60
Tesla Hidey Hole (Richmond, VA)- Don't believe the numbers tomorrow but the ERDF is real.
r/stocks · Apr 2, 2025
The post expresses strong negative sentiment towards Tesla and its practices, suggesting a bearish outlook.
negative -0.60
Page 1 of 2 (9 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙